352 related articles for article (PubMed ID: 19546611)
1. Castleman disease: an update on classification and the spectrum of associated lesions.
Cronin DM; Warnke RA
Adv Anat Pathol; 2009 Jul; 16(4):236-46. PubMed ID: 19546611
[TBL] [Abstract][Full Text] [Related]
2. Castleman's disease.
Palestro G; Turrini F; Pagano M; Chiusa L
Adv Clin Path; 1999; 3(1-2):11-22. PubMed ID: 10655569
[TBL] [Abstract][Full Text] [Related]
3. Castleman disease in an HIV-infected patient with Kaposi sarcoma.
Saif MW
AIDS Read; 2001 Nov; 11(11):572-6. PubMed ID: 11789020
[TBL] [Abstract][Full Text] [Related]
4. Follicular dendritic cell hyperplasia in plasma cell variant of Castleman's disease with interfollicular Hodgkin's disease.
Vasudev Rao T; Alkindi S; Pathare AV
Pathol Res Pract; 2007; 203(6):479-84. PubMed ID: 17418501
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus 8 infections in patients with immunodeficiencies.
Laurent C; Meggetto F; Brousset P
Hum Pathol; 2008 Jul; 39(7):983-93. PubMed ID: 18570975
[TBL] [Abstract][Full Text] [Related]
6. Follicular dendritic cells in multicentric Castleman disease present human herpes virus type 8 (HHV8)-latent nuclear antigen 1 (LANA1) in a proportion of cases and is associated with an enhanced T-cell response.
El-Daly H; Bower M; Naresh KN
Eur J Haematol; 2010 Feb; 84(2):133-6. PubMed ID: 19799625
[TBL] [Abstract][Full Text] [Related]
7. Hyaline vascular Castleman's disease: a case report and brief review of the literature.
van den Berge M; Pauwels P; Jakimowicz JJ; Creemers GJ
Neth J Med; 2002 Dec; 60(11):444-7. PubMed ID: 12685494
[TBL] [Abstract][Full Text] [Related]
8. Castleman disease: the great mimic.
Bonekamp D; Horton KM; Hruban RH; Fishman EK
Radiographics; 2011 Oct; 31(6):1793-807. PubMed ID: 21997995
[TBL] [Abstract][Full Text] [Related]
9. Failure of rituximab in human immunodeficiency virus-associated multicentric Castleman disease.
Neuville S; Agbalika F; Rabian C; Brière J; Molina JM
Am J Hematol; 2005 Aug; 79(4):337-9. PubMed ID: 16044438
[TBL] [Abstract][Full Text] [Related]
10. Pathology of bone marrow in human herpes virus-8 (HHV8)-associated multicentric Castleman disease.
Bacon CM; Miller RF; Noursadeghi M; McNamara C; Du MQ; Dogan A
Br J Haematol; 2004 Dec; 127(5):585-91. PubMed ID: 15566362
[TBL] [Abstract][Full Text] [Related]
11. HHV-8+, EBV+ multicentric plasmablastic microlymphoma in an HIV+ Man: the spectrum of HHV-8+ lymphoproliferative disorders expands.
Seliem RM; Griffith RC; Harris NL; Beheshti J; Schiffman FJ; Longtine J; Kutok J; Ferry JA
Am J Surg Pathol; 2007 Sep; 31(9):1439-45. PubMed ID: 17721201
[TBL] [Abstract][Full Text] [Related]
12. Castleman's disease. Update on pathogenesis.
Al-Maghrabi JA
Saudi Med J; 2011 May; 32(5):451-8. PubMed ID: 21556463
[TBL] [Abstract][Full Text] [Related]
13. Orbital involvement in Castleman disease.
Venizelos I; Papathomas TG; Papathanasiou M; Cheva A; Garypidou V; Coupland S
Surv Ophthalmol; 2010; 55(3):247-55. PubMed ID: 20070998
[TBL] [Abstract][Full Text] [Related]
14. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection.
Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U
J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infection.
Menke DM; Chadbum A; Cesarman E; Green E; Berenson J; Said J; Tiemann M; Parwaresch R; Thome SD
Am J Clin Pathol; 2002 Feb; 117(2):268-75. PubMed ID: 11863223
[TBL] [Abstract][Full Text] [Related]
16. Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma.
Naresh KN; Rice AJ; Bower M
Am J Surg Pathol; 2008 Jul; 32(7):1006-12. PubMed ID: 18469709
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow findings in multicentric Castleman disease in HIV-negative patients.
Kreft A; Weber A; Springer E; Hess G; Kirkpatrick CJ
Am J Surg Pathol; 2007 Mar; 31(3):398-402. PubMed ID: 17325481
[TBL] [Abstract][Full Text] [Related]
18. TdT+ T-lymphoblastic populations are increased in Castleman disease, in Castleman disease in association with follicular dendritic cell tumors, and in angioimmunoblastic T-cell lymphoma.
Ohgami RS; Zhao S; Ohgami JK; Leavitt MO; Zehnder JL; West RB; Arber DA; Natkunam Y; Warnke RA
Am J Surg Pathol; 2012 Nov; 36(11):1619-28. PubMed ID: 23060347
[TBL] [Abstract][Full Text] [Related]
19. Development of a Hodgkin disease tumor in the neck of a patient who previously had undergone complete excision of a hyaline-vascular Castleman disease neck mass.
Unsal Tuna EE; Ozbek C; Arda N; Ilkdogan E; Dere H; Ozdem C
Ear Nose Throat J; 2010 Apr; 89(4):E20-3. PubMed ID: 20397132
[TBL] [Abstract][Full Text] [Related]
20. Multicentric Castleman disease with cutaneous manifestations: report of 2 cases and comparison with systemic plasmacytosis.
Higashi Y; Kanekura T; Sakamoto R; Mochitomi Y; Kanzaki T
Dermatology; 2007; 214(2):170-3. PubMed ID: 17341868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
